Wezlana (ustekinumab)

pCPA File Number: 22413
Negotiation Status:
Concluded with an LOI
Indication(s):
Multiple indications
Sponsor/Manufacturer:
Amgen Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: